-
公开(公告)号:EP1273571A1
公开(公告)日:2003-01-08
申请号:EP01921809.8
申请日:2001-04-11
发明人: YAMAZAKI, Toru , MARUOKA, Hiroshi , SUZUKI, Shigeru , MUKADE, Tsutomu , HIROSE, Kunitaka , YANAKA, Mikiro , YAMAMOTO, Naoki
IPC分类号: C07D207/335
CPC分类号: C07D207/335 , A61K31/4155 , A61K31/4164 , A61K31/4184 , A61K31/427 , A61K31/4402 , A61K31/4406 , A61K31/4436 , A61K31/4439 , A61K31/47 , A61K31/4709 , A61K31/496 , A61K31/497 , A61K31/502 , A61K31/506 , A61K31/5377 , C07D213/38 , C07D215/40 , C07D233/48 , C07D233/64 , C07D235/14 , C07D307/79 , C07D311/70 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D417/12
摘要: The present invention provides novel compounds having antiviral activities and antiviral drugs containing the compounds as the active ingredient. The compounds are shown by the following general formula (1),
wherein typically A 1 and A 2 are each guanidine or a group of the general fomula (ia) ; A 3 is a mono- or poly-cyclic heteroaromatic ring contining 1 or 2 heteroatoms ; B 1 is a single bond or alkylene group; R 1 is hydrogen or alkyl group; W is an alkylene having 2-3 carbons, a cycloalkylene having 5-10 carbons, aromatic ring having 6-10 carbons, or a heteroaromatic ring having 5-10 carbons; y is C(=O)-; x is -C(=O)-NH-; n 1 is an integer of 1-2; n 2 is an integer of 2-3; D is a substituent selected from among various groups.摘要翻译: 本发明提供具有抗病毒活性的新化合物和含有该化合物作为活性成分的抗病毒药物。 所述化合物由以下通式(1)表示,其中通常A 1和A 2分别是胍或一般化的基团(ia); A 3是连续1或2个杂原子的单环或多环杂芳环; B 1是单键或亚烷基; R 1是氢或烷基; W是具有2-3个碳的亚烷基,具有5-10个碳的亚环烷基,具有6-10个碳的芳族环,或具有5-10个碳的杂芳族环; y为C(= O) - ; x是-C(= O)-NH-; n 1是1-2的整数; n 2是2-3的整数; D是选自各种基团中的取代基。
-
公开(公告)号:EP1069113A1
公开(公告)日:2001-01-17
申请号:EP99905278.0
申请日:1999-02-23
发明人: YANAKA, Mikiro , SUZUKI, Shigeru , NISHIJIMA, Fuyuhiko , TAKAHASHI, Hiroshi , SUGANO, Mikio , MARUOKA, Hiroshi , YAMAZAKI, Toru , DEWA, Toshikazu , ENARI, Hiroyuki , ISE, Michihito
IPC分类号: C07D235/26 , C07D235/30 , A61K31/415 , A61K31/40 , A61K31/445 , A61K31/535
CPC分类号: C07D235/26 , C07D235/30
摘要: A novel benzimidazole derivative [specifically, for example, 2-ethoxy-1-[{4'-(2''-N,N-dimethylaminoethoxycarbonyl)phenyl}methyl]-1H-benzimidazole-6-carboxylic acid morpholide] represented by formula (I) and a salt thereof. The compound exhibits satisfactory curative effects for cardiac and nephric diseases, although having little action on blood-pressure.
摘要翻译: 一种新的苯并咪唑衍生物,特别是例如由式(I)表示的2-乙氧基-1-Ç4' - (2“ - N,N-二甲基氨基乙氧基羰基)苯基甲基-1H-苯并咪唑e-6-羧酸吗啉代和盐 它们。 该化合物对心脏和肾脏疾病表现出令人满意的治疗效果,尽管对血压几乎没有作用。
-